Estimated GFR Associates with Cardiovascular Risk Factors Independently of Measured GFR
- 1 May 2011
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American Society of Nephrology
- Vol. 22 (5), 927-937
- https://doi.org/10.1681/asn.2010050479
Abstract
Estimation of the GFR (eGFR) using creatinine- or cystatin C–based equations is imperfect, especially when the true GFR is normal or near-normal. Modest reductions in eGFR from the normal range variably predict cardiovascular morbidity. If eGFR associates not only with measured GFR (mGFR) but also with cardiovascular risk factors, the effects of these non–GFR-related factors might bias the association between eGFR and outcome. To investigate these potential non–GFR-related associations between eGFR and cardiovascular risk factors, we measured GFR by iohexol clearance in a sample from the general population (age 50 to 62 years) without known cardiovascular disease, diabetes, or kidney disease. Even after adjustment for mGFR, eGFR associated with traditional cardiovascular risk factors in multiple regression analyses. More risk factors influenced cystatin C–based eGFR than creatinine-based eGFR, adjusted for mGFR, and some of the risk factors exhibited nonlinear effects in generalized additive models (P < 0.05). These results suggest that eGFR, calculated using standard creatinine- or cystatin C–based equations, partially depends on factors other than the true GFR. Thus, estimates of cardiovascular risk associated with small changes in eGFR must be interpreted with caution.Keywords
This publication has 39 references indexed in Scilit:
- Cystatin C is not a better estimator of GFR than plasma creatinine in the general populationKidney International, 2010
- Method of Glomerular Filtration Rate Estimation Affects Prediction of Mortality RiskJournal of the American Society of Nephrology, 2009
- Association between Cigarette Smoking and Chronic Kidney Disease in Japanese MenHypertension Research, 2008
- Renal Function and Risk of Coronary Heart Disease in General Populations: New Prospective Study and Systematic ReviewPLoS Medicine, 2007
- Association of Cystatin C With Mortality, Cardiovascular Events, and Incident Heart Failure Among Persons With Coronary Heart DiseaseCirculation, 2007
- The association between atherosclerotic risk factors and renal function in the general populationKidney International, 2005
- Clinical Usefulness of Cystatin C for the Estimation of Glomerular Filtration Rate in Type 1 DiabetesDiabetes Care, 2002
- Cardiovascular disease risk profilesAmerican Heart Journal, 1991
- Glomerular filtration rate estimated from a single plasma sample after contrast‐enhanced radiological examinationsClinical Physiology and Functional Imaging, 1988